# Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-for-screening-testing-and-management-of-blood-donors-and-blood-and-blood-components-based-on-screening-tests-for-syphilis-guidance-for-industry/55e82ed9-047c-4235-9442-7dc1d1a9a4d0

> FDA guidance document: Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis:  Guidance for Industry. Issue date: December 02, 2020. Get complete insights and analysis.

---

## Details

- Title: Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2020-12-02
- Last Changed: 2021-01-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2003-D-0128">FDA-2003-D-0128</a>

## Related Documents

- [Human Gene Therapy for Rare Diseases:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-rare-diseases-guidance-for-industry/1cebc8e2-7d3b-4c5f-a4c4-78d1fc112099)
- [Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bacterial-risk-control-strategies-for-blood-collection-establishments-and-transfusion-services-to-enhance-the-safety-and-availability-of-platelets-for-transfusion-guidance-for-industry/333bd28f-2882-4660-b183-54b97fa26003)
- [Human Gene Therapy for Hemophilia:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/human-gene-therapy-for-hemophilia-guidance-for-industry/bceafce9-c9f0-4137-9ca5-071464212a06)